* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Variable regions of a human anti-DNA antibody 0
Bisulfite sequencing wikipedia , lookup
Gene expression wikipedia , lookup
Zinc finger nuclease wikipedia , lookup
Genomic library wikipedia , lookup
Biosynthesis wikipedia , lookup
Copy-number variation wikipedia , lookup
Genetic engineering wikipedia , lookup
Gene therapy of the human retina wikipedia , lookup
Gene nomenclature wikipedia , lookup
Gene regulatory network wikipedia , lookup
Non-coding DNA wikipedia , lookup
Transcriptional regulation wikipedia , lookup
Nucleic acid analogue wikipedia , lookup
Endogenous retrovirus wikipedia , lookup
Gene therapy wikipedia , lookup
Vectors in gene therapy wikipedia , lookup
Monoclonal antibody wikipedia , lookup
Promoter (genetics) wikipedia , lookup
Gene desert wikipedia , lookup
Community fingerprinting wikipedia , lookup
Point mutation wikipedia , lookup
Silencer (genetics) wikipedia , lookup
Nucleic Acids Research, Vol. 20, No. 10 2601 © 7992 Oxford University Press Variable regions of a human anti-DNA antibody 0-81 possessing lupus nephritis-associated idiotype Yasuhiko Hirabayashi, Yasuhiko Munakata, Takeshi Sasaki* and Hiroshi Sano1 The Second Department of Internal Medicine, Tohoku University School of Medicine, Seiryo-cho 1-1, Aoba-ku, Sendai 980 and biotechnology Institute, Akita Prefectural College of Agriculture, Minami 2-2, Ogata-mura, Akita 010-04, Japan Submitted April 7, 1992 An anti-DNA antibody idiotype (Id), termed 0-81 Id, was in the antigen-binding sites of human IgM monoclonal anti-single stranded (ss) DNA antibodies secreted from the 0-81 clone, derived from a patient with active lupus nephritis (1, 2). The O-81 Id was specifically detected in circulating immune complex IgG and renal immune deposits of patients with lupus nephritis (3,4). The paratopes of O-81 were responsible for the idiotypic expression of 0-81 (unpublished data). These findings suggested that the sequence analysis of 0-81 may contribute to understanding the origin of pathogenic autoantibodies in humans. Poly(A+)RNA was prepared from cells of O-81 clone by using Micro Fast Track (Invitrogen, San Diego, CA) and used to prepare ss-cDNA which was primed with oligo-d(T)|2_i8 primer. For amplification of the variable regions by polymerase chain reaction (PCR) the following primers were used: VH3-leader 5' ATGGAGTTTGGGCTGAGC 3', Qi 5' TGGAAGAGGCACGTTCTTTTC 3', Vk2-leader 5' GAAGCTTATGAGGCTCCCTGCTC 3', Ck 5' TCTAGAACTAACACTCTCCCCTGTTGAAGCTCTTTGTGACGGGCAAG 3'. The products were digested by EcoRI (heavy chain) and Hindm-Xbal Gight chain), respectively, and were ligated into the vector pUCl 18. Sequences were determined by the chain termination method. To avoid misincorporation of TaqI polymerase, DNA amplification was independently performed three times and at least one clone was obtained at each time. The sequences of these clones were identical. The nucleotide sequences revealed V H 3 - D H Q 5 2 - J H 4 and VK2-JK5. The VH segment of 0-81 showed the highest homology with the V H m germline H l l gene (5), with 86.9% matching (leader-FR3). It was also 86.9% homologous with the FL2-2 gene obtained from cDNA library of fetal liver (6). The VK segment was 98.1% homologous with the germline V6410 gene (7). It was suggested that the VK segment was encoded by the V6410 gene or its relative genes but the VH segment might be originated from an unreported VH3 germline gene. EMBL accession nos X59134 and X59135 REFERENCES 1. Sasaki.T., Endo.F., Sekiguchi.Y., Mikami.M., Tada.K., Ishida.N. and Yoshinaga.K. (1984) J. Immunol. Methods 72, 157. 2. Tamate.E., Sasaki.T., Muryoi.T., Takai,O., Otani,K., Tada,K. and Yoshinaga.K. (1986) J. Immunol. 136, 1241. 3. Muryoi.T., Sasaki.T., Hatakeyama,A., Shibata.S., Seino.T. and Yoshinaga.K. (1990) J. Immunol. 144, 3856. 4. Sasaki.T., Muryoi.T., Hatakeyama.A., Suzuki,M., Sato.H., Seino.J., Saito.T. and Yoshinaga.K. (1991) Am. J. Med. 91, 335. 5. Rechavi.G., Bienz.B., Ram.D., Ben-Neriah.Y., Cohen.J.B., Zakut.R. and Givol.D. (1982) Proc. Nail. Acad. Sci. USA 79, 4405. 6. Nickerson.K.G., Berman.J., Glickman.E., Chess.L. and Alt.F.W. (1989) J. Exp. Med. 169, 1391. 7. Klobeck.H.G., Meindl.A., Combriato.G., Solomon.A. and Zachau.H.G. (1985) Nucleic Acids Res. 13, 6499. Heavy chain Leader ATGGACTTTi V Q t V GCGAAGACGCT) E S G G C L V Q P G G S L R L rra3CCAACGTGAACCAGGATGGAAGTGCCAGGTACTATGCG CACTCTGTGAGGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAACTCACTATATCTC D S V R G R F T I 8 R D N A K N S L Y L CAAATGCACAGCCTCACAGCCCAOyWACGGCCGTGTATTACTGTGCCACATCAACCGGC Q H P S L R A D D T A V Y Y C A R S T G TAATCCTCTGGGTCCCAGGATCCAGTCCC ATCTCCTGCAGGTCTACTCAAACCCTCGTACACAGTGATGGAAACACCTACTTGAATTGG I S C R S S O S L V H S D G N T Y L N W rrTCACCAGAGGCCAGGCCAATCTCCAACGCGTCTAATTTATACCGTTTCTAACCGCGAC F 0 0 R P C Q 8 P H B L I Y R V S H R 0 ACATTCAGCGCCAGTGGCTCAGGCACTGATTTCACACTGAAAATC ACKNOWLEDGEMENTS This work was supported by a grant-in-aid for Scientific Research from the Ministry of Education, Science and Culture, and by a research grant for autoimmune diseases from the Ministry of Health and Welfare, Japan. * To whom correspondence should be addressed Figure 1. Nucleotide and deduced amino acid sequences encoding the VH and VK regions of the O-81. Asterisks indicate complementary determing regions (CDR).